N-[2-(3-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid)
C24H21F6N5O6 — CID 117077962
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(3-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid)
N-[2-(3-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid) (PubChem CID 117077962) has the molecular formula C24H21F6N5O6 and a molecular weight of 589.45 g/mol. Its IUPAC name is N-[2-(3-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | N-[2-(3-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid) |
|---|---|
| PubChem CID | 117077962 |
| Molecular Formula | C24H21F6N5O6 |
| Molecular Weight | 589.45 g/mol |
| Exact Mass | 589.14 |
| IUPAC Name | N-[2-(3-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid) |
| SMILES | COc1cccc(CCNC(=O)c2n[nH]c3cc(-c4cn[nH]c4)ccc23)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C20H19N5O2.2C2HF3O2/c1-27-16-4-2-3-13(9-16)7-8-21-20(26)19-17-6-5-14(10-18(17)24-25-19)15-11-22-23-12-15;2*3-2(4,5)1(6)7/h2-6,9-12H,7-8H2,1H3,(H,21,26)(H,22,23)(H,24,25);2*(H,6,7) |
| InChIKey | VKPVLRCBVBYFAJ-UHFFFAOYSA-N |
| XLogP | 4.20 |
| TPSA | 170.29 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 589.45 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117077962 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.